All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity
1997

All-trans retinoic acid and gastric cancer cell resistance

publication Evidence: moderate

Author Information

Author(s): TY Chao, SY Jiang, RY Shyu, MY Yeh, TM Chu

Primary Institution: National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan; Roswell Park Cancer Institute, Buffalo, NY, USA

Hypothesis

Does all-trans retinoic acid affect the sensitivity of gastric cancer cells to lymphokine-activated killer activity?

Conclusion

All-trans retinoic acid significantly increases the resistance of gastric cancer cells to lymphokine-activated killer cytotoxicity.

Supporting Evidence

  • RA treatment led to a dose-dependent increase in resistance to LAK activity.
  • The maximum resistance was observed after 6 days of treatment with RA.
  • RA did not alter the binding efficacy between target SC-Mi cells and effector LAK cells.

Takeaway

This study found that a substance called all-trans retinoic acid helps stomach cancer cells become tougher against certain immune attacks.

Methodology

The study involved co-culturing gastric cancer cells with all-trans retinoic acid and assessing their resistance to lymphokine-activated killer cells through various assays.

Limitations

The study primarily focused on in vitro results, which may not fully translate to in vivo conditions.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication